MNG
ABBV icon

Manning & Napier Group’s AbbVie ABBV Stock Holding History

Manning & Napier Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-440,566
Closed -$47.7M – 286
2021
Q1 		$47.7M Buy
440,566
+8,491
+2% +$908K 0.4% 72
2020
Q4 		$46.3M Sell
432,075
-27,966
-6% -$2.69M 0.43% 69
2020
Q3 		$40.3M Buy
460,041
+6,262
+1% +$590K 0.41% 71
2020
Q2 		$44.6M Sell
453,779
-3,372
-0.7% -$297K 0.48% 64
2020
Q1 		$34.8M Sell
457,151
-2,773
-0.6% -$236K 0.41% 64
2019
Q4 		$40.7M Buy
459,924
+38,385
+9% +$3.19M 0.44% 61
2019
Q3 		$31.9M Buy
421,539
+2,250
+0.5% +$154K 0.36% 71
2019
Q2 		$30.5M Buy
419,289
+39,969
+11% +$3.14M 0.33% 74
2019
Q1 		$30.6M Buy
379,320
+83,583
+28% +$6.84M 0.33% 68
2018
Q4 		$27.3M Buy
295,737
+9,118
+3% +$802K 0.33% 62
2018
Q3 		$27.1M Buy
286,619
+20,976
+8% +$1.99M 0.27% 79
2018
Q2 		$24.6M Sell
265,643
-10,003
-4% -$977K 0.24% 83
2018
Q1 		$26.1M Buy
275,646
+40,902
+17% +$4.49M 0.26% 78
2017
Q4 		$22.7M Buy
+234,744
New +$22.1M 0.2% 85

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Manning & Napier Group's ABBV Position: Q2 2021 in Review

Manning & Napier Group sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 440,566 shares — an estimated $47.7M sold.

Manning & Napier Group first reported a position in ABBV in Q4 2017 and held it in 14 quarters. The position peaked at $47.7M in Q1 2021. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Manning & Napier Group reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
  • Manning & Napier Group sold 440,566 AbbVie shares in Q2 2021, an estimated $47.7M.
  • Manning & Napier Group first reported a position in AbbVie in Q4 2017 and held it in 14 quarters.
  • Manning & Napier Group's AbbVie position peaked at $47.7M in Q1 2021.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Manning & Napier Group's 13F filing for Q2 2021, filed 19 Jul 2021.